Inhibition activity prediction for a dataset of candidates' drug by combining fuzzy logic with MLR/ANN QSAR models

Opportunities and challenges in application of artificial intelligence in pharmacology

Artificial intelligence (AI) is a machine science that can mimic human behaviour like intelligent analysis of data. AI functions with specialized algorithms and integrates with deep and machine learning. Living in the digital world can generate a huge amount of medical data every day. Therefore, we need an automated and reliable evaluation tool that can make decisions more accurately and faster. Machine learning has the potential to learn, understand and analyse the data used in healthcare systems. In the last few years, AI is known to be employed in various fields in pharmaceutical science especially in pharmacological research. It helps in the analysis of preclinical (laboratory animals) and clinical (in human) trial data. AI also plays important role in various processes such as drug discovery/manufacturing, diagnosis of big data for disease identification, personalized treatment, clinical trial research, radiotherapy, surgical robotics, smart electronic health records, and epidemic outbreak prediction. Moreover, AI has been used in the evaluation of biomarkers and diseases. In this review, we explain various models and general processes of machine learning and their role in pharmacological science. Therefore, AI with deep learning and machine learning could be relevant in pharmacological research.

MLP-Based Regression Prediction Model For Compound Bioactivity

The development of breast cancer is closely linked to the estrogen receptor ERα, which is also considered to be an important target for the treatment of breast cancer. Therefore, compounds that can antagonize ERα activity may be drug candidates for the treatment of breast cancer. In drug development, to save manpower and resources, potential active compounds are often screened by establishing compound activity prediction model. For the 1974 compounds collected, the top 20 molecular descriptors that significantly affected the biological activity were screened using LASSO regression models combined with 10-fold cross-validation method. Further, a regression prediction model based on the MLP fully connected neural network was constructed to predict the bioactivity values of 50 new compounds. To measure the validity of the model, the model loss term was specified as the mean squared error (MSE). The results showed that the MLP-based regression prediction model had a loss value of 0.0146 on the validation set. This model is therefore well trained and the prediction strategy used is valid. The methods developed by this paper may provide a reference for the development of anti-breast cancer drugs.

Modelling in Synthesis and Optimization of Active Vaccinal Components

Cancer is the second leading cause of mortality worldwide, behind heart diseases, accounting for 10 million deaths each year. This study focusses on adenocarcinoma, which is a target of a number of anticancer therapies presently being tested in medical and pharmaceutical studies. The innovative study for a therapeutic vaccine comprises the investigation of gold nanoparticles and their influence on the immune response for the annihilation of cancer cells. The model is intended to be realized using Quantitative-Structure Activity Relationship (QSAR) methods, explicitly artificial neural networks combined with fuzzy rules, to enhance automated properties of neural nets with human perception characteristics. Image processing techniques such as morphological transformations and watershed segmentation are used to extract and calculate certain molecular characteristics from hyperspectral images. The quantification of single-cell properties is one of the key resolutions, representing the treatment efficiency in therapy of colon and rectum cancerous conditions. This was accomplished by using manually counted cells as a reference point for comparing segmentation results. The early findings acquired are conclusive for further study; thus, the extracted features will be used in the feature optimization process first, followed by neural network building of the required model.

Versatile modelling of polyoxymethylene-water partition coefficients for hydrophobic organic contaminants using linear and nonlinear approaches

Environmental fate or transport of hydrophobic organic contaminants (HOCs) depends on the partitioning properties of compounds within various environmental phases. Due to the wide application of polyoxymethylene (POM) in the passive sampling technique, several in silico models were developed to predict POM-water partition coefficients (K_POM-w) in accordance with the guidelines of the Organization for Economic Cooperation and Development (OECD). It is an attempt to combine conventional linear method (multiple linear regression, MLR) and popular nonlinear algorithm (artificial neural network, ANN) for estimating partition coefficients of HOCs. All models were performed on a dataset of 210 chemicals from 13 different classes. The polyparameter linear free energy relationship (pp-LFER) model included 5 molecular descriptors, namely, E, S, A, B and V, and predicted log K_POM-w with R²_adj of 0.825. The values of statistical parameters including R²_adj, Q²_ext, RMSE_tra and RMSE_ext for quantitative structure-property relationship (QSPR)-MLR and QSPR-ANN models with four descriptors (ALOGP, MeanDD, E1m and Mor24s) were: (0.928, 0.877, 0.498 and 0.649) and (0.943, 0.905, 0.443 and 0.571), with high similarity for both models, which confirmed the robustness, significance, and remarkable prediction accuracy of the QSPR models. Moreover, the mechanism interpretation revealed that the molecular volume and hydrophobicity had a major impact on distribution procedure of HOCs. The models developed herein, with the broad applicability domain (AD), provide suitable tools to fill the experimental data gap for untested chemicals and help researchers better understand the mechanistic basis of adsorption behavior of POM.

QSPR/QSAR: State-of-Art, Weirdness, the Future

Ability of quantitative structure-property/activity relationships (QSPRs/QSARs) to serve for epistemological processes in natural sciences is discussed. Some weirdness of QSPR/QSAR state-of-art is listed. There are some contradictions in the research results in this area. Sometimes, these should be classified as paradoxes or weirdness. These points are often ignored. Here, these are listed and briefly commented. In addition, hypotheses on the future evolution of the QSPR/QSAR theory and practice are suggested. In particular, the possibility of extending of the QSPR/QSAR problematic by searching for the "statistical similarity" of different endpoints is suggested and illustrated by an example for relatively "distanced each from other" endpoints, namely (i) mutagenicity, (ii) anticancer activity, and (iii) blood-brain barrier.